Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
2000-2-10
pubmed:databankReference
pubmed:abstractText
We have identified a retinol dehydrogenase (cRDH) that catalyzes the oxidation of 9-cis- but not all-trans-retinol and proposed that this enzyme plays an important role in synthesis of the transcriptionally active retinoid, 9-cis-retinoic acid. There is little information regarding either the biochemical properties of cRDH or how its 9-cis-retinol substrate is formed. We now report studies of the properties and expression of human and mouse cRDH and of the characteristics and location of the murine cRDH gene. Additionally, we report mouse hepatic 9-cis-retinol concentrations and demonstrate that 9-cis-retinol is formed in a time- and protein-dependent manner upon incubation of all-trans -retinol with cell homogenate. Human and mouse cRDH display similar substrate specificities for cis-isomers of retinol and retinaldehyde. Moreover, human and mouse cRDH show marked sensitivity to inhibition by 13-cis-retinoic acid, with both being inhibited by approximately 50% by 0.15 microm 13-cis-retinoic acid (for substrate concentrations of 10 microm). Lesser inhibition is seen for 9-cis- or all-trans-retinoic acids. Immunoblot analysis using antiserum directed against human cRDH demonstrates cRDH expression in several tissues from first trimester human fetuses, indicating that cRDH is expressed early in embryogenesis. Adult mouse brain, liver, kidney, and to a lesser extent small intestine and placenta express cRDH. The murine cRDH gene consists of at least 5 exons and spans approximately 6 kb of genomic DNA. Backcross analysis mapped the mouse cRDH gene to the most distal region of chromosome 10. Taken together, these data extend our understanding of the properties of cRDH and provide additional support for our hypothesis that cRDH may play an important role in 9-cis-retinoic acid formation.
pubmed:grant
pubmed:keyword
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0022-2275
pubmed:author
pubmed:issnType
Print
pubmed:volume
40
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2279-92
pubmed:dateRevised
2009-9-9
pubmed:meshHeading
pubmed-meshheading:10588954-Alcohol Oxidoreductases, pubmed-meshheading:10588954-Animals, pubmed-meshheading:10588954-Blotting, Northern, pubmed-meshheading:10588954-CHO Cells, pubmed-meshheading:10588954-Chromosome Mapping, pubmed-meshheading:10588954-Cricetinae, pubmed-meshheading:10588954-DNA, Complementary, pubmed-meshheading:10588954-Female, pubmed-meshheading:10588954-Fetus, pubmed-meshheading:10588954-Genes, pubmed-meshheading:10588954-Humans, pubmed-meshheading:10588954-Immune Sera, pubmed-meshheading:10588954-Immunoblotting, pubmed-meshheading:10588954-Male, pubmed-meshheading:10588954-Mice, pubmed-meshheading:10588954-Molecular Sequence Data, pubmed-meshheading:10588954-Oxidation-Reduction, pubmed-meshheading:10588954-Pregnancy, pubmed-meshheading:10588954-Retinaldehyde, pubmed-meshheading:10588954-Sequence Analysis, DNA, pubmed-meshheading:10588954-Sequence Homology, Nucleic Acid, pubmed-meshheading:10588954-Substrate Specificity, pubmed-meshheading:10588954-Tissue Distribution, pubmed-meshheading:10588954-Transcription, Genetic, pubmed-meshheading:10588954-Tretinoin, pubmed-meshheading:10588954-Vitamin A
pubmed:year
1999
pubmed:articleTitle
Biochemical properties, tissue expression, and gene structure of a short chain dehydrogenase/ reductase able to catalyze cis-retinol oxidation.
pubmed:affiliation
Institute of Human Nutrition, College of Physicians and Surgeons, Columbia University, 630 W. 168th Street, New York, NY 10032, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S.